genten therapeutics inc  biotechnology johnson formdscom  sec filings of fundraisings and investments in hedge funds private equity firms startups and growing companies formdscom newest filter local genten therapeutics inc industry biotechnology see others in industry address  montgomery street suite  san francisco ca phone  filings date filingtype reported sold incremental cash type exemptions link to raw filing  new   equity only b sec link directors and executives current and past name role craig johnson director executive david mauney director executive   bizapediacom  human validation companiespeopleproductsservicestrademarksaddressesphone book our system has detected a high number of page requests from your ip address please prove to us that you are a human to continue using our website please send me to the search subscription offer page after i successfully answer the word challenge bizapediapro searchperform unlimited searches via ouradvanced search form withbizapedia pro searchfind out more bizapediapro databuild custom data listsfor one or many stateswith bizapedia pro datafind out more  copyright   · bizapediacom · all rights reservedblogpro searchpro apicontact usterms of useprivacy policysitemapdesktop version bizapediacom  human validation companiespeopleproductsservicestrademarksaddressesphone book our system has detected a high number of page requests from your ip address please prove to us that you are a human to continue using our website please send me to the search subscription offer page after i successfully answer the word challenge bizapediapro searchperform unlimited searches via ouradvanced search form withbizapedia pro searchfind out more bizapediapro databuild custom data listsfor one or many stateswith bizapedia pro datafind out more  copyright   · bizapediacom · all rights reservedblogpro searchpro apicontact usterms of useprivacy policysitemapdesktop version genten therapeutics inc  who is raising money  sec filings of fundraisings and investments in hedge funds startups and private equity companies who is raising money genten therapeutics inc funding details genten therapeutics inc industry biotechnologycik number irs number address  montgomery street san francisco phone number  latest news genten therapeutics inc raised  from  investors on  genten therapeutics inc filings datefiling typeofferedsoldremainingmin investmentinvest countexemption  exlusions new form dbsec filing genten therapeutics inc raised  in total directors and executives of genten therapeutics inc key people in genten therapeutics inc david mauneycraig johnson last visited companies murvin  meier oil co navigator investors l p next big sound inc oregon film group llc paamco ak absolute return fund ltd partnership  whoisraisingmoneycom daily updated news about investment into startups hedge funds and private equity companies genten therapeutics inc  list of ceos founders and company directors directorpedianet  list of ceos founders board members and company directors genten therapeutics inc list of persons related to the company genten therapeutics inc find out list of ceos founders board members and company directors of genten therapeutics inc cik number irs number company address  montgomery street san francisco phone number  people related to genten therapeutics inc namepositionstreetcitycountryr johnson craig montgomery street suite san franciscocamauney david montgomery street suite san franciscoca genten therapeutics inc on the web actobiotic for celiac disease  product profile  biocentury publications archives bciq conferences version  free trial  subscribe sign in english   한국어 biocentury menu home  publications  publications home  biocentury bc innovations bc extra bc week in review current issues archives  archives home  basic search advanced search back issues bciq  bciq home  overview pipeline analyst financial analyst company analyst deal analyst conferences  conferences home  newsmakers bio€quity europe future leaders china healthcare summit other industry events elearning  elearning home  videos white papers follow us bciq  product profile bciq overview      settings      support biocentury print this       actobiotic for celiac disease print preview bookmark share with colleague general information company intrexon corp descriptionactobiotic delivering immunogenic antigens of gluten molecular target mechanism of action  therapeutic modalitybiologic protein latest stage of developmentpreclinical standard indicationceliac disease indication detailstreat celiac disease regulatory designation partnergenten therapeutics inc  product summary number of indications in each phase of development by disease category more  product details  archive items are loading deals information  deals summary total number of dealstotal deal valuetotal upfront cashtotal milestone payments   deals details datecompanies involveddeal headlinetotal deal valuetotal upfront cashtotal milestone intrexon licensorgenten licenseeintrexon grants genten therapeutics exclusive access to its actobiotics platform to deliver therapies against celiac diseaseundisclosedundisclosed about biocentury company overview management editorial  research contact contact us advertising  sponsorship career opportunities support forgot password customer service reprints faqs products  solutions products overview publications archives bciq conferences elearning rss feeds legal user agreement terms of use privacy policy your california privacy rights use of images follow us what is biocentury biocentury employs a fully integrated multimedia platform — including publications video online data solutions and conferences — to provide its audience with authoritative and uptodate intelligence about corporate strategy partnering emerging technology clinical data public policy and the financial markets sign in free trial   biocentury inc all rights reserved    terms  conditions  privacy policy set email alert dummy genten therapeutics inc private company information  bloomberg july    pm et biotechnology company overview of genten therapeutics inc snapshot people company overview genten therapeutics inc develops a monotherapy through an antigen specific induction of immune tolerance for gluten the company was incorporated in  and is based in san francisco california  montgomery streetsuite san francisco ca united statesfounded in  phone  key executives for genten therapeutics inc mr david mauney executive director mr craig johnson executive director compensation as of fiscal year  similar private companies by industry company name region n labs inc united states andme inc united states c tech corporation inc united states v biosciences inc united states bar biologics inc united states recent private companies transactions typedate target private placement september    request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup most searched private companies company name geographic region lawyers committee for civil rights under law united states nyc inc united states the advertising council inc united states bertelsmann ag europe rush university united states sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact genten therapeutics inc please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close secgems form d genten therapeutics inc  data feeds now available excel  csv  java  python etc database learn more genten therapeutics inc d    notice of exempt offering of securities  made without registration  regulation d and section  small businesses  filing date oct   effectiveness date oct   date of filing date change oct   signed by edward y kim accession number  type d public document count  items descs b federal exemptions and exclusions rule b new contact looking to load all form d filings easily into a spreadsheet or database subscribe to files containing this and over  form d filings from   now easily sort  filtergraph offerings based on offering amount citystate industry investors and every field seen in this filing load in microsoft excel  google sheets developers csv files work with python  java  databases etc api access get access to all filings  old and new via realtime api realtime alerts for this and all other form types key documents and exhibits link type id filename d d  primarydocxml primary issuer genten therapeutics inc  corporation  jurisdiction delaware  montgomery street suite  san francisco  ca   usa  related persons david mauney  executive officer   director   montgomery street  suite   san francisco  ca    usa craig johnson  executive officer   director   montgomery street  suite   san francisco  ca    usa industry biotechnology offering data revenue range decline to disclose date of first sale   equity  total offer   total sold   total remaining    investors  investors have already invested in this offering signature genten therapeutics inc  edward y kim  edward y kim  assistant secretary   type filing company sic rel irs  state of inc fy end mailing address former filing vals filer genten therapeutics inc cik   montgomery street san francisco  ca     usa  usa  de    montgomery street san francisco  ca     usa form typed act file number film number genten therapeutics inc  company profile  biocentury publications archives bciq conferences version  free trial  subscribe sign in english   한국어 biocentury menu home  publications  publications home  biocentury bc innovations bc extra bc week in review current issues archives  archives home  basic search advanced search back issues bciq  bciq home  overview pipeline analyst financial analyst company analyst deal analyst conferences  conferences home  newsmakers bio€quity europe future leaders china healthcare summit other industry events elearning  elearning home  videos white papers follow us bciq  company profile bciq overview      settings      support biocentury print this       genten therapeutics inc print preview export bookmark share with colleague general information  location germantown md  region midatlantic  country us  business category autoimmune  year founded   website  lead product status discovery  archive items are loading  financial information  financing summary  financing details  earnings summary  stocks annual chart  pipeline information  pipeline summary  pipeline details  deals information  deals summary  deals details about biocentury company overview management editorial  research contact contact us advertising  sponsorship career opportunities support forgot password customer service reprints faqs products  solutions products overview publications archives bciq conferences elearning rss feeds legal user agreement terms of use privacy policy your california privacy rights use of images follow us what is biocentury biocentury employs a fully integrated multimedia platform — including publications video online data solutions and conferences — to provide its audience with authoritative and uptodate intelligence about corporate strategy partnering emerging technology clinical data public policy and the financial markets sign in free trial   biocentury inc all rights reserved    terms  conditions  privacy policy set email alert dummy